Treatment Effectiveness
User reported effectiveness ratings Quetiapine for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Depression | 0% | 33% | 0% | 67% | 0% | 3 |
Side Effects
User-reported side effects of Quetiapine
| Side Effect | Percent of Reports Quetiapine |
|---|---|
| Irritability | 46% |
| Constipation | 27% |
| Dry Mouth | 55% |
| Breast Enlargement in Males | 5% |
| Decreased Sexual Desire or Ability | 54% |
| Difficulty Speaking or Using Language | 28% |
| Difficulty Thinking or Concentrating | 67% |
| Discharge From the Breasts | 3% |
| Dizziness | 60% |
| Drowsiness | 89% |
| Excessive Weight Gain | 40% |
| Increased Appetite | 47% |
| Loss of Coordination | 38% |
| Missed Menstrual Periods | 3% |
| Numbness, Burning, or Tingling in the Arms or Legs | 12% |
| Pain in the Joints, Back, Neck, or Ears | 23% |
| Stomach Pain or Swelling | 20% |
| Stuffy Nose | 21% |
| Unusual Dreams | 47% |
| Weakness | 41% |
| Headache | 30% |
| Gas | 24% |
| Indigestion | 24% |
Outcomes
Below is the degree of change seen after Quetiapine is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Quetiapine Info
| Property | Value |
|---|---|
| Variable Name | Quetiapine |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-17 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 94993 |